MSI Financial Services’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$1M Buy
3,541
+466
+15% +$138K 0.03% 443
2016
Q3
$963K Sell
3,075
-161
-5% -$47.7K 0.03% 439
2016
Q2
$782K Sell
3,236
-106
-3% -$27.9K 0.03% 478
2016
Q1
$870K Sell
3,342
-162
-5% -$42.8K 0.04% 417
2015
Q4
$1.07M Buy
3,504
+1,120
+47% +$322K 0.05% 344
2015
Q3
$696K Buy
2,384
+23
+1% +$7.59K 0.05% 327
2015
Q2
$954K Buy
2,361
+224
+10% +$89.9K 0.07% 303
2015
Q1
$902K Buy
2,137
+263
+14% +$104K 0.06% 332
2014
Q4
$636K Buy
1,874
+536
+40% +$173K 0.07% 311
2014
Q3
$443K Buy
1,338
+77
+6% +$25.4K 0.05% 369
2014
Q2
$398K Buy
1,261
+78
+7% +$23.5K 0.05% 376
2014
Q1
$362K Buy
1,183
+777
+191% +$247K 0.05% 373
2013
Q4
$114K Buy
406
+60
+17% +$15.5K 0.02% 711
2013
Q3
$83K Sell
346
-311
-47% -$69.6K 0.01% 704
2013
Q2
$141K Buy
+657
New +$140K 0.03% 512

Other funds holding BIIB

MSI Financial Services's BIIB Position: Q4 2016 in Review

MSI Financial Services increased its Biogen (BIIB) stake by 15% in Q4 2016, buying an estimated $138K and bringing the position to 3,541 shares worth $1M. The position accounts for 0.03% of the portfolio, ranked #443.

MSI Financial Services first reported a position in BIIB in Q2 2013 and has held it in 15 quarters since. The position peaked at $1.07M in Q4 2015. 1,025 funds tracked by Wall St. Rank hold BIIB as of Q4 2016.

  • MSI Financial Services held 3,541 shares of Biogen worth $1M as of Q4 2016.
  • MSI Financial Services bought 466 Biogen shares in Q4 2016, an estimated $138K.
  • Biogen made up 0.03% of MSI Financial Services's portfolio in Q4 2016, its #443 holding.
  • MSI Financial Services first reported a position in Biogen in Q2 2013 and has held it in 15 quarters since.
  • MSI Financial Services's Biogen position peaked at $1.07M in Q4 2015.
  • 1,025 funds tracked by Wall St. Rank held Biogen as of Q4 2016.

Based on MSI Financial Services's 13F filing for Q4 2016, filed 13 Jan 2017.